ArticleBMC endocrine disorders2022

Durvalumab-induced thyroiditis in a patient with non-small cell lung carcinoma: a case report and review of pathogenic mechanisms.

Jeroen M K de Filette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.